|
|
|
The Clearant Process® uses a combination of patented and
trade secret technology based on gamma irradiation that substantially reduces all types of pathogens
including:
enveloped and non-enveloped viruses
the vegetative, spore or cyst stages of bacteria, fungi and protozoa
The Clearant Process substantially inactivates these types of
pathogens while maintaining the integrity of the biological product in human hard- and soft-tissue
allografts. This patented technology inactivates all types of viruses - including HIV and Hepatitis A
and Hepatitis C. The Clearant Process also achieves a
level of microbial sterility that meets or exceeds that of an operating room medical device without
impacting the structural or biomechanical integrity of the allograft. The implant maintains strength
and elasticity, and integrates well with surrounding tissue.
The Clearant Process is an extensively researched
methodology with more than 10,000 tests to measure efficacy, and more than 8,000 successful human
implants. Studies show radiation performed within the optimized conditions of the
Clearant Process maintains impressive allograft strength
and elasticity.
Unlike other current pathogen inactivation or sterlization techniques, the
Clearant Process can be applied at various stages of
product processing/manufacturing including in the final container.
|
|
(click for detailed image)
|
|
|
;)